Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

CUSIP: 23285D109

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 6 signals
Share change
+667,797
SEC-reported price per share
$16.32
Number of holders
51
Value change
-$4,872,187
Number of buys
30
Number of sells
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,694,583

Security key

23285D109

Report period

Q4 2021

Institutions

51

Top holders

10

Ownership snapshot

Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $205,686,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $205.69M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $205.69M
HHLR ADVISORS, LTD. $187.49M
FIL Ltd $57.09M
FMR LLC $57.09M
Miura Global Management, LLC $45.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$205,686,000
9,607,028 shares
— 30 Sep 2021
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$187,488,000
8,757,030 shares
— 30 Sep 2021
FIL Ltd
13F
Company
13F
—
denominator unverified
$57,092,000
2,666,600 shares
— 30 Sep 2021
FMR LLC
13F
Company
13F
—
denominator unverified
$57,092,000
2,666,600 shares
— 30 Sep 2021
Miura Global Management, LLC
13F
Company
13F
—
denominator unverified
$45,336,000
2,117,500 shares
— 30 Sep 2021
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$41,174,000
1,923,139 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
51
Shares
35,038,930
Rows available
51
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q4 2025 Across Filers

Q4 2025 holders
155
Q4 2021 holders
51
Holder diff
-104
Investor Q4 2025 Shares Q4 2021 Shares Share Diff Share Chg % Q4 2025 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .